wegian perhaps do some research
ALT have given MLA the distribution rights in Australia and New Zealand only. This is roughly an $88M market.
US and EUR is the $3Bn annual market which ALT has no exclusivity with MLA.
ALT are currently in discussions with majors in the US and Latin America.
MLA are negotiating with QLD Health and RPA.
Whilst success with QLD Health and RPA would be excellent for both companies, ALT has significantly more upside.
Add to My Watchlist
What is My Watchlist?